{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/diarrhoea-antibiotic-associated/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"788d8348-35a0-5147-b765-a90a068257b9","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field 198c23f4-f06a-4249-94ff-50c0303e170a --><h2>How common is it?</h2><!-- end field 198c23f4-f06a-4249-94ff-50c0303e170a -->","summary":"","htmlStringContent":"<!-- begin item e32fc438-a3be-4cf6-b05d-715d63a50125 --><!-- begin field 518feb8c-5b20-4632-a346-b525be73b782 --><ul><li><strong>Antibiotic-associated diarrhoea is estimated to occur in 2–25% of people taking antibiotics, depending on the antibiotic prescribed </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/diarrhoea-antibiotic-associated/references/\">Bartlett, 2002</a>]<strong>.</strong><ul><li>The rates of diarrhoea are similar for parenteral and oral antibiotic administration [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diarrhoea-antibiotic-associated/references/\">Bartlett, 2002</a>].</li></ul></li><li><strong>Around 20–30% of cases of antibiotic-associated diarrhoea are due to Clostridium difficile </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/diarrhoea-antibiotic-associated/references/\">Steele et al, 2015</a>]<strong>.</strong></li><li><strong>The number of <em>C. difficile </em>infections are falling across the NHS.</strong><ul><li>The number of <em>C. difficile</em> infections in the NHS in England decreased substantially from 2007/08 to 2013/14, falling from 55,498 cases to 13,361 cases. This has been attributed to surveillance programmes, measures to control antibiotic prescribing, and implementation of and compliance with isolation and hygiene protocols [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diarrhoea-antibiotic-associated/references/\">NICE, 2015b</a>].</li></ul></li><li><strong>Asymptomatic carriage of <em>C. difficile</em>:</strong><ul><li><strong>Children under 2 years old </strong>— in healthy newborn babies and infants, asymptomatic colonisation of <em>C. difficile </em>is very common [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diarrhoea-antibiotic-associated/references/\">Williams and Spencer, 2009</a>]. Up to 50% of infants may be colonized in the first few months of life, but it rarely presents as symptomatic disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diarrhoea-antibiotic-associated/references/\">PHE, 2018a</a>].</li><li><strong>Adults </strong>— asymptomatic colonisation of <em>C. difficile </em>occurs in less than 2% of adults without recent healthcare contact, 5–7% of residents of long-term care facilities, and 3–26% of adult inpatients in acute care hospitals [<a class=\"bibliography-reference internal-reference\" href=\"/topics/diarrhoea-antibiotic-associated/references/\">McDonald et al, 2018</a>].</li></ul></li></ul><!-- end field 518feb8c-5b20-4632-a346-b525be73b782 --><!-- end item e32fc438-a3be-4cf6-b05d-715d63a50125 -->","topic":{"id":"e3d5d597-cb8d-5009-95be-96d5f61f622c","topicId":"60505e59-3d44-4100-ba77-670b2dda81a3","topicName":"Diarrhoea - antibiotic associated","slug":"diarrhoea-antibiotic-associated","lastRevised":"Last revised in November 2020","chapters":[{"id":"ff00d31e-fff0-5539-893c-63eaae28aa91","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d4f02cb1-a605-5763-85b8-7e30efe0b52d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b4be21a4-fea2-52ee-99b9-6ad9b7f42b37","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"14b5fd2c-0a9a-58b3-af3b-54e8f6c587a3","slug":"changes","fullItemName":"Changes"},{"id":"86cd74d6-6f35-5de4-9031-55397958409b","slug":"update","fullItemName":"Update"}]},{"id":"d9b8d789-d6e6-5a0f-80ef-2853843c67b6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"93a9787b-a3ca-5bd2-9dd1-e7bd5ebd7e61","slug":"goals","fullItemName":"Goals"},{"id":"712c6134-ba14-5e2a-987b-8d3c06033ee0","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"04b62294-302f-5852-90f5-60c1f9593a96","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"98b4954c-4b96-5b7a-9888-99cfd0b2ce3d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7f04cf05-c2de-5fb3-9f58-b7e32b7a8604","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d849aa0f-051e-5e61-8d05-6da99fdc60e0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"146be3ba-ef2c-5d7c-a6be-75d743b6cbdb","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3deeffef-b60e-557b-a9ce-2ca055de0653","slug":"definition","fullItemName":"Definition"},{"id":"788d8348-35a0-5147-b765-a90a068257b9","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7804f825-6a78-5c22-89f7-9ecb4f2ac588","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"4d2b177e-1c5d-5783-b256-b0b7173e4660","slug":"complications","fullItemName":"Complications"},{"id":"0d3b3c20-ff70-5653-9cb1-750667c15098","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"db6311c9-b63f-5037-89f3-fe2ed41761c7","fullItemName":"Management","slug":"management","subChapters":[{"id":"1ddecd55-2bf4-53db-8594-8c1489126404","slug":"diarrhoea-antibiotic-associated","fullItemName":"Scenario: Diarrhoea - antibiotic associated"}]},{"id":"e0650ec6-ca9b-5cf0-9761-2ffe00571666","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4f209e3e-56a5-5f47-859e-8b6f0b9b9fe9","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"1a19af07-ea9e-59ac-8ce6-508d4d01e536","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ecd4dd69-cf4c-507f-9659-b23f2a5b3272","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b0079d2b-b8c1-59e3-a1c1-f6f2c83a07c5","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"919502d7-1740-58a4-8ea5-2feeb47d6e28","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d1844305-0beb-50de-a2de-fbea6a58b880","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"766c971f-c448-56d3-a9d4-2ffded846f90","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7d18a1e0-eeb3-5b2f-bd26-e9f231d83c40","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"99309640-cab2-57c4-8bd0-2c05065abd69","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"146be3ba-ef2c-5d7c-a6be-75d743b6cbdb","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}